Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2007
11/01/2007US20070256192 By expression of pathogen inducible expression of a sucrose isomerase; transgenic plants and plant organs
11/01/2007US20070256191 Plants and seeds of corn variety i539440
11/01/2007US20070256190 Soybean variety 4309194
11/01/2007US20070256189 Soft alignment in gaussian mixture model based transformation
11/01/2007US20070256188 Sowing a culture medium containing a plant growth factor (auxin) with a monocotyledonous seed (rice), conducting culturing for 1 to 3 days so as to effect germination and infecting the seed with agrobacterium
11/01/2007US20070256187 Soybean variety 4175567
11/01/2007US20070256186 Soybean variety 4336643
11/01/2007US20070256185 Soybean variety 4671685
11/01/2007US20070256184 Soybean variety 0330738
11/01/2007US20070256183 Soybean variety 0045477
11/01/2007US20070256182 Soybean variety 0437973
11/01/2007US20070256181 Soybean variety 0457028
11/01/2007US20070256180 Soybean variety 0367478
11/01/2007US20070256179 Soybean variety 0358232
11/01/2007US20070256178 Soybean variety 0417158
11/01/2007US20070256177 Soybean variety 4559809
11/01/2007US20070256176 Soybean variety 0196172
11/01/2007US20070256175 Soybean variety 4785923
11/01/2007US20070256174 Soybean variety 4587513
11/01/2007US20070256173 Soybean variety 0409670
11/01/2007US20070256172 Soybean variety 4010165
11/01/2007US20070256171 Soybean variety 0421133
11/01/2007US20070256170 Soybean variety 0240187
11/01/2007US20070256147 Combinatorial marking of cells and cell structures with reconstituted fluorescent proteins
11/01/2007US20070256146 Pufa polyketide synthase systems and uses thereof
11/01/2007US20070256145 Mammalian transforming growth factor beta-9
11/01/2007US20070255053 Random-primed reverse transcriptase - in vitro transcription method for rna amplification
11/01/2007US20070255052 siRNA targeting v-myc myelocytomatosis viral oncogene homolog (MYC)
11/01/2007US20070255051 efficient sequence specific gene silencing; gene expression inhibition; increases siRNA efficacy
11/01/2007US20070255050 siRNA targeting minichromosome maintenance deficient 2, mitotin (MCM2)
11/01/2007US20070255049 siRNA targeting EPH receptor A3 (EPHA3)
11/01/2007US20070255048 siRNA targeting discoidin domain receptor family, member 1 (DDR1)
11/01/2007US20070255047 siRNA targeting cell division cycle 6 homolog (CDC6)
11/01/2007US20070255046 siRNA targeting spectrin SH3 domain binding protein 1 (SSH3BP1)
11/01/2007US20070255044 Preparing immunoglobulins specific to galanin binding protein for use in treatment and prevention of nervous system disorders
11/01/2007US20070255043 MN gene and protein
11/01/2007US20070255041 Bioengineered Vehicles for Targeted Nucleic Acid Delivery
11/01/2007US20070254851 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/01/2007US20070254850 Methods for Treating and Preventing Apoptosis-Related Diseases Using Rna Interfering Agents
11/01/2007US20070254844 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/01/2007US20070254838 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
11/01/2007US20070254368 Method for simultaneous display of target protein and cofactor regenerating enzyme on cell surface
11/01/2007US20070254367 Methods for extending the life span of marine invertebrate cells
11/01/2007US20070254362 COMPOSITIONS AND METHODS EMPLOYING UNIVERSAL-BINDING NUCLEOTIDES FOR TARGETING MULTIPLE GENE VARIANTS WITH A SINGLE siRNA DUPLEX
11/01/2007US20070254360 Expression vector comprising nucleotide sequences coding dorsal-ventral patterning fusion protein for use as tool in enhancement of immune response in infected cells
11/01/2007US20070254358 Culture medium for cell growth and transfection
11/01/2007US20070254357 Gene therapy using replication competent targeted adenoviral vectors
11/01/2007US20070254354 Production of Isoprenoids
11/01/2007US20070254351 Vessicular composition comprising hepatitis C virus RNA sequences for use in designing drugs for treatment and prevention of viral infection
11/01/2007US20070254350 Modulation of Inhibition of Ferrochelatase by N-Methyl Protoporphyrin
11/01/2007US20070254342 Process for Plasmid Dna Fermentation
11/01/2007US20070254341 by organism cell biosynthesis from 6-aminohex-2-enoic acid or transform 6-amino-2-hydroxy-hexanoic acid to 6-aminohex-2-enoic acid, in presence of an enzyme having alpha, beta -enoate reductase; chemical intermediates for nylon-6 production
11/01/2007US20070254338 Method for making recombinant protein using complementation dependent DHFR mutants
11/01/2007US20070254337 Transgenic microorganism for use as bioreator for synthesis of amino acids to be use in animal feeds and pharmaceuticals
11/01/2007US20070254336 Transcription Factors
11/01/2007US20070254335 Novel expression vector system regulated by Sigma32 and methods for using it to produce recombinant protein
11/01/2007US20070254334 Prokaryotic host cells for expressing proteins rich in disulfide bonds
11/01/2007US20070254313 Gnal Splice Variant and Uses Thereof
11/01/2007US20070254302 Compositions and methods for the diagnosis and treatment of tumor
11/01/2007US20070254298 Atropisomers of asymmetric xanthene fluorescent dyes and method of dna sequencing and fragment analysis
11/01/2007US20070254297 KCNQ2 and KCNQ3 - potassium channel genes which are mutated in Benign Familial Neonatal Convulsions (BFNC) and other epilepsies
11/01/2007US20070254291 Gene Targeting in Eukaryotic Cells by Group II Intron Ribonucleoprotein Particles
11/01/2007US20070254283 Brhf1 as a Cancer Diagnostic Marker
11/01/2007US20070254282 Catalytic Polynucleotide and Its Use for Determination of Analytes
11/01/2007US20070254022 Cationic liposome delivery of taxanes to angiogenic blood vessels
11/01/2007US20070253982 Compositions that include hemagglutinin, methods of making and methods of use thereof
11/01/2007US20070253981 Canine influenza virus
11/01/2007US20070253977 Recombinant respiratory syncytial virus (RSV) strains deleted of the region of G protein most likely to induce unwanted type 2 T cell responses in susceptible recipients; engineered using reverse genetics with deletions of amino acids 151-221 and 178-219; for immunogenic compositions against RSV
11/01/2007US20070253974 Elicits the production of antibodies that interfere with invasion by Babesia bovis into erythrocytes, diagnosis
11/01/2007US20070253972 For expressing foreign genetic information, e.g. foreign genes, for many applications, including immunogenic or pharmaceutical compositions for pathogens other than mumps, gene therapy, and cell targeting
11/01/2007US20070253971 Circovirus sequences associated with piglet weight loss disease (PWD)
11/01/2007US20070253968 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
11/01/2007US20070253964 Novel Immunogenic Compositions for the Prevention and Treatment of Meningococcal Disease
11/01/2007US20070253963 Epithelial cell specific growth factor keratinocyte growth factor (KGF)
11/01/2007US20070253958 Human monoclonal antibodies to FC gamma receptor II (CD32)
11/01/2007US20070253956 Method for opening tight junctions
11/01/2007US20070253955 Methods for altering fertility
11/01/2007US20070253954 Epha4 As Therapeutic Target Of Prc And Pdaca
11/01/2007US20070253952 Multifunctional and Multivalent Angiogenesis Inhibitors
11/01/2007US20070253936 Self-complementary parvoviral vectors, and methods for making and using the same
11/01/2007US20070253935 Surface expression method of peptides p5 and anal3 using the gene encoding poly-gamma-glutamate synthetase
11/01/2007US20070253933 Carotene Synthase Gene and Uses Therefor
11/01/2007US20070253932 Recombinant adenoviral vectors and methods of use
11/01/2007US20070253907 Non Human Transgenic Animal as Model of Neurodegenerative Diseases and for the Early Diagnosis Thereof
11/01/2007US20070252295 Amphoteric liposomes containing positive and negative membrane-based or membrane forming charge carriers and having an isoelectric point of between 4 and 8; pH-sensitive liposomes comprise, in particular, cholesterol hemisuccinate
11/01/2007CA2650699A1 Diagnostic agent and therapeutic agent for pancreatic cancer
11/01/2007CA2650465A1 Tomato plants having higher levels of resistance to botrytis
11/01/2007CA2650229A1 Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene
11/01/2007CA2649920A1 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
11/01/2007CA2649800A1 Hgf precursor protein variant and active protein thereof
11/01/2007CA2649770A1 Mutated acvr1 for diagnosis and treatment of fibrodyplasia ossificans progressiva (fop)
11/01/2007CA2649734A1 Isolated polynucleotide molecules corresponding to mutant and wild-type alleles of the maize d9 gene and methods of use
11/01/2007CA2649732A1 Methods for detecting mutations in jak2 nucleic acid
11/01/2007CA2649535A1 Thermostable proteins and methods of making and using thereof
11/01/2007CA2649020A1 Means for inhibiting the expression of cd31
11/01/2007CA2648499A1 Transgenic plants and methods for controlling bolting in sugar beet
11/01/2007CA2648481A1 Pestivirus species
11/01/2007CA2648030A1 Compositions and methods comprising the use of cell surface displayed homing endonucleases
11/01/2007CA2647768A1 Ige directed dna vaccination
11/01/2007CA2647685A1 Short interfering rna duplexes targeting an ires sequence and uses thereof